| LB17 compare to other probiotics |
|
|
| Anti-tumour activity of D-fraction from Maitake mushroom |
| Maitake D-fraction inhibit carcinogenesis and metastasis |
| Sparassis crispa mushroom SCG 1,3-beta-D-glucan effect on luokopenic mice |
| Functional properties of edible mushrooms |
| Maitake mushroom effects on liver serums and lipids |
|
|
|
Himmenmatustake (Agaricus blazei) (20%)
The polysaccharides contained in Agaricus blazei mushroom vitalize production of interferon and interleukin. This is referred to as a cytokine inducing effect and can also prevent viruses and other external factors from entering the cell tissue.
Previous clinical trials showed that many fungi polysaccharides are effective only against solid cancer. This was reported during the general convention of the Japan Cancer Association in 1980. Subsequent studies, in collaboration with universities and hospital researchers, proved that the polysaccharides of Agaricus blazei is effective agains Ehrilch's ascites carcinoma sigmoid colnic cancer, ovarian cancer, breast cancer, lung cancer, liver cancer as well as solid cancer. These experiments suggested that it activated metabolism by revitalizing normal biological tissues. It was only recently that melanin protein, which is effective in the production of semen, hair and egg white, was discovered in Agaricus blazei.
The mushroom activates macrophage, immunocytes such as complements
retculoendothelial system, acts to induce cytokine such as interferon as well as BRM. It bolsters the body's immune system.
The above information is provided for general
educational purposes only. It is not intended to replace competent
health care advice received from a knowledgeable healthcare professional.
You are urged to seek healthcare advice for the treatment of any
illness or disease.
Health Canada and the FDA (USA) have not evaluated these
statements. This product is not intended to diagnose, treat, cure, or prevent
any disease.
|
|
15 or 30 sachets per box
$45 or $85 per box
|
